Home › Bids
› Early Stage Testing of Pharmacologic or Neuromodulatory Devi
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
This grant opportunity (PAR-25-184) funds early-stage testing of pharmacologic or neuromodulatory device-based interventions for mental disorders. It requires a clinical trial and utilizes an R61/R33 phased award mechanism.
Want the full details?
Sign up free to see the agency name and the original bid posting link, plus contracting-officer contacts and AI response outlines. Every feature is free through December 31, 2026.